251 related articles for article (PubMed ID: 17100932)
1. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
Park K; Kim SW; Rhu KS; Paick JS
J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
[TBL] [Abstract][Full Text] [Related]
5. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
6. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat.
Wingard C; Fulton D; Husain S
J Sex Med; 2007 Mar; 4(2):348-62; discussion 362-3. PubMed ID: 17367430
[TBL] [Abstract][Full Text] [Related]
7. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
[TBL] [Abstract][Full Text] [Related]
10. Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice.
Steioff K; Rütten H; Busch AE; Plettenburg O; Ivashchenko Y; Löhn M
Eur J Pharmacol; 2005 Apr; 512(2-3):247-9. PubMed ID: 15840411
[TBL] [Abstract][Full Text] [Related]
11. Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
Badejo AM; Dhaliwal JS; Casey DB; Gallen TB; Greco AJ; Kadowitz PJ
Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L828-36. PubMed ID: 18689606
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
Okamura N; Saito M; Mori A; Sakamoto K; Kametaka S; Nakahara T; Ishii K
J Ocul Pharmacol Ther; 2007 Jun; 23(3):207-12. PubMed ID: 17593003
[TBL] [Abstract][Full Text] [Related]
13. Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.
Teixeira CE; Ying Z; Webb RC
J Pharmacol Exp Ther; 2005 Oct; 315(1):155-62. PubMed ID: 15976017
[TBL] [Abstract][Full Text] [Related]
14. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
[TBL] [Abstract][Full Text] [Related]
15. Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis.
Park K; Son H; Kim SW; Paick JS
Int J Impot Res; 2005; 17(5):424-30. PubMed ID: 15889122
[TBL] [Abstract][Full Text] [Related]
16. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
Wingard CJ; Moukdar F; Prasad RY; Cathey BL; Wilkinson L
J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):269-78. PubMed ID: 19267849
[TBL] [Abstract][Full Text] [Related]
17. [Fasudil improves erectile function of hypertensive rats].
Ma ZP; Jiang R; Cheng Y; Yang HF; Chen F
Zhonghua Nan Ke Xue; 2012 Jan; 18(1):11-5. PubMed ID: 22295842
[TBL] [Abstract][Full Text] [Related]
18. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
19. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
Wu DJ; Xu JZ; Wu YJ; Jean-Charles L; Xiao B; Gao PJ; Zhu DL
Atherosclerosis; 2009 Nov; 207(1):68-73. PubMed ID: 19473657
[TBL] [Abstract][Full Text] [Related]
20. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
